WAC 182-527-2734 Liens during a client's lifetime.

WAC 182-527-2734 Liens during a client's lifetime.

Effective July 1, 2017

For the pur­poses of this section, the term "agency" includes the agency's desig­nee.

  1. When the agency may file.
    1. The agency may file a lien against the property of a Washing­ton apple health client during the client's lifetime if:
      1. The client resides in a skilled nursing facility, intermedi­ate care facility for individuals with an intellectual disability, or other medical institution under WAC 182-500-0050;
      2. The agency determines that a client cannot reasonably be expected to return home because:
        1. The agency receives a physician's verification that the client will not be able to return home; or
        2. The client has resided for six months or longer in an institution as defined in WAC 182-500-0050; and
      3. None of the following people lawfully reside in the client's home:
        1. The client's spouse or state-registered domestic partner;
        2. The client's child who is age twenty or younger, or is blind or permanently disabled as defined in WAC 182-512-0050; or
        3. A client's sibling who has an equity interest in the home and who has been residing in the home for at least one year immediately before the client's admission to the medical institution.
    2. If the client returns home from the medical institution, the agency releases the lien.
  2. Amount of the lien.
    1. The agency may file a lien to recoup the cost of all non-MAGI-based and deemed eligible services under WAC 182-503-0510 it correctly purchased on the client's behalf, regardless of the client's age on the date of service.
    2. Services provided under the medicaid transformation project, defined in WAC 182-500-0070, are excluded when determining the amount of the lien.
  3. Notice requirement.
    1. Before the agency may file a lien under this section, it sends notice via first class mail to:
      1. The client's last known address;
      2. The client's authorized representative, if any;
      3. The address of the property subject to the lien; and
      4. Any other person known to hold title to the property.
    2. The notice states:
      1. The client's name;
      2. The agency's intent to file a lien against the client's property;
      3. The county in which the property is located; and
      4. How to request an administrative hearing.
  4. Interest assessed on past-due debt.
    1. Interest on a past-due debt accrues at a rate of one percent per month under RCW 43.17.240.
    2. A lien under this section becomes a past-due debt when the agency has recorded the lien in the county where the property is loca­ted and:
      1. Thirty days have passed since the property was transferred or
      2. Nine months have passed since the lien was filed.
    3. The agency may waive interest if reasonable efforts to sell the property have failed.
  5. Administrative hearing. An administrative hearing under this section is governed by WAC 182-527-2753.

This is a reprint of the official rule as published by the Office of the Code Reviser. If there are previous versions of this rule, they can be found using the Legislative Search page.

WAC 182-520-0015 Long-term services and supports client overpayments.

WAC 182-520-0015 Long-term services and supports client overpay­ments.

Effective December 9, 2025

  1. General right to recover.
    1. A long-term services and supports (LTSS) client overpayment is any payment for LTSS made by the agency or the agency's designee on a client's behalf in excess of that to which the client is legally en­titled.
    2. An LTSS client overpayment may be caused by:
      1. A client or a client's authorized representative misstating or failing to reveal a fact affecting eligibility under WAC 182-503-0505;
      2. A client or a client's authorized representative failing to timely report a change required under WAC 182-504-0105; or
      3. The agency or the agency's designee's error.
    3. The agency or the agency's designee may recoup an LTSS client overpayment:
      1. Up to six years after the date of the notice in subsection (2) of this section; and
      2. Regardless of whether the program is state-funded, federally funded, or both.
    4. The amount of the LTSS client overpayment equals the amount the agency or the agency's designee paid on the client's behalf minus the amount to which the client was legally entitled.
    5. When the agency or the agency's designee determines it caused the overpayment, the agency or the agency's designee may grant exceptions to client recovery.
  2. Notice.
    1. The agency notifies the client or the client's authorized representative by:
      1. Personal service under RCW 4.28.080; or
      2. Certified mail, return receipt requested.
    2. The agency or the agency's designee may prove that it noti­fied the client by providing:
      1. A sworn statement;
      2. An affidavit or certificate of mailing; or
      3. The certified mail receipt signed by the client or the cli­ent's authorized representative.
    3. The notice states:
      1. The client's name;
      2. The client's address;
      3. The date the agency or the agency's designee issued the no­tice;
      4. The amount of the LTSS client overpayment;
      5. How the agency calculated the LTSS client overpayment;
      6. How the client may request an administrative hearing; and
      7. How the client may make a payment.
  3. Response.
    1. The client must respond to the notice within 90 days of the date the agency or the agency's designee served the client with the notice of the LTSS client overpayment by:
      1. Paying the agency or the agency's designee;
      2. Establishing a payment plan with the agency or the agency's designee; or
      3. Requesting an administrative hearing.
    2. If the client does not respond to the notice within 90 days of the date the agency or the agency's designee served the client with the notice, the agency or the agency's designee may initiate col­lection action.
  4. Hearings. A person who disagrees with agency or the agency's designee's action under this section may request an administrative hearing under chapter 182-526 WAC.

This is a reprint of the official rule as published by the Office of the Code Reviser. If there are previous versions of this rule, they can be found using the Legislative Search page.

WAC 182-501-0200 Third-party resources.

WAC 182-501-0200 Third-party resources.

Effective August 6, 2021

  1. The medicaid agency requires a provider to seek timely reimbursement from a third party when a client has available third-party resources, except as described under subsections (2) and (3) of this section.
  2. The agency pays for medical services and seeks reimbursement from a liable third party when the claim is for preventive pediatric services as covered under the early and periodic screening, diagnosis and treatment (EPSDT) program.
  3. The agency pays for medical services and seeks reimbursement from any liable third party when both of the following apply:
    1. The provider submits to the agency documentation of billing the third party and the provider has not received payment after one hundred days from the date of services; and
    2. The claim is for a covered service provided to a client on whose behalf the office of support enforcement is enforcing a noncustodial parent to pay support. For the purpose of this section, "is enforcing" means the noncustodial parent either:
      1. Is not complying with an existing court order; or
      2. Received payment directly from the third party and did not pay for the medical services.
  4. The provider may not bill the agency or the client for a covered service when a third party pays a provider the same amount as or more than the agency rate.
  5. When the provider receives payment from a third party after receiving reimbursement from the agency, the provider must refund to the agency the amount of the:
    1. Third-party payment when the payment is less than the agency's maximum allowable rate; or
    2. Agency payment when the third-party payment is equal to or more than the agency's maximum allowable rate.
  6. The agency does not pay for medical services if third-party benefits are available to pay for the client's medical services when the provider bills the agency, except under subsections (2) and (3) of this section.
  7. The client is liable for charges for covered medical services that would be paid by the third-party payment when the client either:
    1. Receives direct third-party reimbursement for the services; or
    2. Fails to execute legal signatures on insurance forms, billing documents, or other forms necessary to receive insurance payments for services rendered. See WAC 182-503-0540 for assignment of rights.
  8. The agency considers an adoptive family to be a third-party resource for the medical expenses of the birth mother and child only when there is a written contract between the adopting family and either the birth mother, the attorney, the provider, or the adoption service. The contract must specify that the adopting family will pay for the medical care associated with the pregnancy.
  9. A provider cannot refuse to furnish covered services to a client because of a third-party's potential liability for the services.
  10. For third-party liability on personal injury litigation claims, the agency or managed care organization (MCO) is responsible for providing medical services under WAC 182-501-0100.

This is a reprint of the official rule as published by the Office of the Code Reviser. If there are previous versions of this rule, they can be found using the Legislative Search page.

WAC 182-554-500 Covered enteral nutrition products, equipment and related supplies - Orally administered - Clients twenty years of age and younger only.

WAC 182-554-500 Covered orally administered enteral nutrition products, equipment and related supplies - Clients age twenty and younger only.

Effective May 1, 2017

  1. Subject to the prior authorization requirements and limitations in this section, and in the Enteral Nutrition Program Billing Guide, the agency covers orally administered enteral nutrition products for clients age twenty and younger.
  2. The agency's enteral nutrition program is not a food benefit. All clients under age five who qualify for supplemental nutrition from the women, infants, and children (WIC) nutrition program must receive products and formulas directly from that program. The agency may cover orally administered enteral nutrition products for a client under age five if the client has a WIC information form that verifies:
    1. The client is not eligible for the WIC program;
    2. The client is eligible for the WIC program, but the client's need for an oral enteral nutrition product or formula exceeds the amount allowed by WIC rules; or
    3. The client is eligible for the WIC program, but a medically necessary product or formula is not available through the WIC program.
  3. With expedited prior authorization, the agency covers orally administered enteral nutrition products for a one-time, initial one-month supply if the client:
    1. Has or is at risk of growth or nutrient deficits due to a condition that prevents the client from meeting their needs using food, over-the-counter nutrition products, standard infant formula, or standard toddler formula; and
    2. Has completed the agency's enteral nutrition products prescription form (HCA 13-961).
  4. With prior authorization (PA), the agency covers a monthly supply of orally administered enteral nutrition products if the client:
    1. Has or is at risk of growth or nutrient deficits due to a condition that prevents the client from meeting their needs using food, over-the-counter nutrition products, standard infant formula, or standard toddler formula;
    2. Has a valid prescription that states the product is medically necessary as defined in WAC 182-500-0070; and
    3. Has a nutrition assessment from a registered dietitian (RD) that includes all of the following:
      1. Evaluation of the client's nutritional status, including growth and nutrient analysis;
      2. An explanation about why the product is medically necessary as defined in WAC 182-500-0070;
      3. A nutrition care plan that monitors the client's nutrition status, and includes plans for transitioning the client to food or food products, if possible; and
      4. Recommendations, as necessary, for the primary care provider to refer the client to other health care providers (for example, gastrointestinal specialists, allergists, speech therapists, occupational therapists, applied behavioral analysis providers, and mental health providers) who will address the client's growth or nutrient deficits as described in (a) of this subsection, and facilitate the client's transition to food or food products.
  5. If a client requires orally administered enteral nutrition products for longer than one month, the client must continue to meet criteria in subsection (4) of this section and receive periodic reevaluations from an RD. Periodic reevaluations:
    1. Must be performed at least three times a year for a client age three or younger;
    2. Must be performed at least two times a year for a client older than age three; and
    3. May be performed face-to-face, or by medical record and growth data review and phone contact with the client or the client's caregiver.
  6. If a client requires orally administered enteral nutrition products for longer than one month, the DME or pharmacy provider must obtain PA from the agency. The request for PA must include all of the following:
    1. Documentation of the client's diagnosis that supports the client's need for the orally administered enteral nutrition product;
    2. The client's nutrition care plan, which must monitor the client's nutrition status, and transition the client to food or food products, if possible, or document why the client cannot transition to food or food products;
    3. Updates to the client's nutrition care plan resulting from subsequent reevaluations;
    4. Updates to the client's growth chart;
    5. Documentation that shows through regular follow up and weight checks how the prescribed product is treating the client's growth or nutrient deficits, or is necessary to maintain the client's growth or nutrient status;
    6. Referrals, if necessary, to other health care providers (for example, gastrointestinal specialists, allergists, speech therapists, occupational therapists, applied behavioral analysis providers, and mental health providers) and show communication of recommendations and treatment plans for the client; and
    7. Documentation of any communication the treating provider has had with other providers, such as those in subsection (4)(c)(iv) of this section, directly or indirectly treating the client's growth or nutrient deficits while the client is receiving orally administered enteral nutrition products.

This is a reprint of the official rule as published by the Office of the Code Reviser. If there are previous versions of this rule, they can be found using the Legislative Search page

This is a reprint of the official rule as published by the Office of the Code Reviser. If there are previous versions of this rule, they can be found using the Legislative Search page.

PEBB Continuation Coverage

PEBB Continuation Coverage

Your PEBB Continuation Coverage benefits include medical, dental, and vision coverage. You may be able to continue your life and long-term disability insurance, depending on the type of continuation coverage you enroll in. If you choose to continue your PEBB benefits, you must pay all the premiums.

Washington Prescription Drug Program (WPDP)

We ensure the value of prescription drug purchasing by the state.

The Washington Prescription Drug Program provides evidence-based prescription drug guidance to state agencies that purchase drugs on behalf of Washington residents. 

Goals

Our goal is to make sure Washington prescription drug consumers get safe medications with proven results at lower prices. We do this through the following methods: 

  • Our evidence-based preferred drug selection process for the Washington Preferred Drug List (WA PDL).
  • ArrayRx Solutions multistate partnership pools prescription drug purchasing power. 
  • ArrayRx prescription drug discount card available to all Washingtonians.

Making informed health care decisions

Health care can be complicated. But as the consumer, you can be an active participant in your health. This page includes resources and tools to help you take charge of your health care.

The Washington State Health Care Authority (HCA) seeks to help residents in improving their health and well-being. These resources can assist you in exploring your health care options.

Choosing a primary care doctor

It's important to have a primary care doctor you know and trust.

Choosing procedures wisely

Some of the most common medical procedures may be overused. The Washington Health Alliance's Choosing Wisely campaign focuses on cervical cancer screening, antibiotics, cardiac and other imaging, and early elective births.

Understanding health insurance coverage

Owning your health

As health care consumers, we have a big role in making sure we get the right care. The Washington Health Alliance's Own Your Health campaign offers tools and resources to help make sure you are getting high quality care, and a good experience at a fair price.

Making shared decisions with your provider

Shared decision making is a process that allows patients and their providers to make health care decisions together, taking into account the best scientific evidence available, as well as the patient’s values and preferences.

Patient decision aids are tools that can help people engage in shared health decisions with their health care provider. Research shows that use of patient decision aids leads to increased knowledge, more accurate risk perception, and fewer patients remaining passive or undecided about their care.

Finding support during serious illness or end of life

Know what your options are when you or a loved one are recovering from a serious illness or entering the end stages of life. 

Medicaid Transformation Project (MTP)

MTP is Washington State's Section 1115 Medicaid demonstration waiver between the Health Care Authority (HCA) and Centers for Medicare & Medicaid Services (CMS). MTP allows our state to create and continue to develop projects, activities, and services that improve Washington’s health care system. 

On June 30, 2023, CMS approved MTP to continue for five more years. Our state's MTP renewal, called MTP 2.0, will help widen our reach to provide more programs, services, and supports to our most vulnerable populations.

An overview of MTP 2.0

To read complete details about the following graphic, read the long description.

See long description below the infographic for details

Long description: MTP 2.0 infographic

The graphic above illustrates the various programs under the Medicaid Transformation Project (MTP) renewal, called MTP 2.0.

On the left side of the graphic

We provide this language about MTP 2.0:

“The Medicaid Transformation Project (MTP) is Washington State’s Section 1115 Medicaid demonstration waiver. MTP allows our state to create and continue to develop projects, activities, and services that improve Washington’s health care system. All MTP programs support Apple Health (Medicaid) enrollees. In June 2023, the federal government approved MTP to continue for an additional five years. We call the MTP renewal ‘MTP 2.0,’ which will help widen our reach to provide more programs, services, and supports to our most vulnerable populations.”

On the bottom left corner

A legend describes how to view the illustration part of the graphic. Each MTP program is designed as a hexagon-shaped tile (with six sides), which connects to a topic (also designed as a hexagon-shaped tile). The topic and program(s) create an individual cluster, and all clusters connect together. Each cluster has a specific color—and depending on if a program is new or continuing—the shade of the cluster will vary. New programs are a darker shade; programs continuing from the initial MTP waiver period have a lighter shade.

The clusters are as follows:

Behavioral health—colored purple—has three programs:

  • Both the mental health IMD and substance use disorder (SUD) IMD programs are continuing from the initial MTP waiver period
  • Contingency management for SUD treatment is a new MTP 2.0 program

Older and aging adults and family caregivers—colored blue—has two programs:

  • Medicaid Alternative Care (MAC) and Tailored Supports for Older Adults (TSOA) are continuing
  • Presumptive Eligibility is new

Housing and employment—colored green—has one program:

  • Foundational Community Supports is continuing

Health-related social needs (HRSN)—colored gold—has three programs:

  • Native Hub, other HRSN services, and Community Hubs are new

HRSN system—colored orange—has one program:

  • HRSN infrastructure is new

Reentry from a carceral setting—colored grey blue—has one program:

  • Reentry services for individuals leaving a prison, jail, or youth correctional facility is new

Continuous enrollment—colored red—has two programs:

  • Continuous Apple Health enrollment for children, ages 0–5 and Apple Health postpartum coverage expansion are new

On the bottom of the graphic

We provide this definition:

“IMD stands for ‘institution for mental diseases.’ IMDs are hospitals, nursing facilities, or other institutions of more than 16 beds that are primarily engaged in providing diagnosis, treatment, or care of persons with mental diseases, which includes SUD. We acknowledge the term ‘mental disease’ may be harmful or stigmatizing. We use it in this context only to reflect the legal terminology used in statute."

Clinical collaboration and initiatives

The Clinical Quality and Care Transformation (CQCT) Division improves health care access, quality, and cost for Washingtonians using evidence to make clear and consistent coverage decisions.

Our division works with providers and manufacturers to stay informed of industry standards and trends. We conduct provider outreach and advise on health care policy.

Our mission is to make clinical policy decisions that guide medical coverage, maintain quality standards, and ensure providers have access to evidence-based practices for medical care.

What we're working on

Clinical program staff work to improve outcomes for issues related to substance use disorders (SUD), primary care in Washington, pharmacy policy and costs, reproductive health, and more.

Substance use disorder treatment

Primary care transformation

Pharmacy programs

Eliminating hepatitis C

Reproductive health

Quality program and initiatives

Other clinical programs and initiatives

Partnerships and collaborations

Contact us

Chief Medical Officer

Email: Judy Zerzan-Thul

Chief Pharmacy Officer

Email: Donna Sullivan

Washington State Opioid Authority

Email: Jessica Blose